Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

611
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
611
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

873
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
873
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

526
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
526
Prochirality02:05

Prochirality

3.8K
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OT-55 reshapes tolerogenic BH3-mimetic-induced apoptosis toward immunogenic cell death in acute myeloid leukemia, potentiating PD-1/Tim-3 blockade.

Cell death & disease·2026
Same author

New Bicyclic Sesquiterpene and Labdane Diterpenes from the Culture Extract of the Sea Grass-Derived Fungus <i>Penicillium verruculosum</i> KUFA1509.

Marine drugs·2026
Same author

The Structures Obtained from the Oxidation of 3-Amino-1<i>H</i>-indazole in Basic Conditions According to Hünig and Pozharskii.

The Journal of organic chemistry·2026
Same author

Exploring the Chemical Profile and Biological Activities of <i>Eryngium dichotomum</i>: UHPLC-MS/NMR Characterization, and In Vitro Antioxidant Activity Along with the Antitumor Effect of Falcarinol.

Molecules (Basel, Switzerland)·2026
Same author

Broad Screening of 2-Styrylchromones Identifies dual inhibitors of the COX-2 pathway.

Methods (San Diego, Calif.)·2026
Same author

Exploiting Laminaria digitata L. Aqueous Extract for Tomato Biostimulation: A Physiological and Metabolomic Approach.

Physiologia plantarum·2026

Related Experiment Video

Updated: Jun 9, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.5K

Styrylchromones: Biological Activities and Structure-Activity Relationship.

Mariana Lucas1, Marisa Freitas1, Artur M S Silva2

  • 1LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira n° 228, 4050-313, Porto, Portugal.

Chemmedchem
|October 31, 2024
PubMed
Summary

Styrylchromones (SC) are versatile heterocyclic compounds with diverse biological activities. This review highlights their potential as a promising scaffold for developing new therapeutic drugs.

Keywords:
2-styrylchromones3-styrylchromonesBiological activityStructure-activity relationship

More Related Videos

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

11.4K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.6K

Related Experiment Videos

Last Updated: Jun 9, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.5K
Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

11.4K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.6K

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Organic Chemistry

Background:

  • Styrylchromones (SC) are oxygen-containing heterocyclic compounds featuring a styryl group attached to a chromone core.
  • While found in nature, SC are predominantly synthesized, with 2-styrylchromones being the most common type.
  • Numerous SC derivatives with varying substituents have been reported in scientific literature.

Purpose of the Study:

  • To comprehensively review the biological activities of styrylchromones (SC).
  • To analyze the structure-activity relationships (SAR) of SC based on literature published since 1989.
  • To assess the potential of SC as a scaffold for novel drug development.

Main Methods:

  • Literature search of published studies on styrylchromones (SC) from 1989 to present.
  • Systematic review and discussion of reported biological activities and SAR.
  • Categorization of biological activities including antioxidant, antiallergic, antiviral, antibacterial, antifungal, anti-inflammatory, antitumoral, adenosine receptor affinity, neuroprotection, and α-glucosidase inhibition.

Main Results:

  • Styrylchromones (SC) exhibit a broad spectrum of significant biological activities.
  • Specific substituents and their positions on the SC scaffold influence biological potency and selectivity.
  • SC have demonstrated potential in various therapeutic areas, including inflammation, infection, cancer, and neurodegenerative diseases.

Conclusions:

  • Styrylchromones (SC) represent a promising class of compounds with diverse pharmacological properties.
  • The SC scaffold holds considerable potential for the rational design and development of new therapeutic agents.
  • Further research into SC SAR is warranted to optimize drug candidates for specific therapeutic targets.